GENETEC | GENETEC TECHNOLOGY BERHAD

1.18 (-4.07%)
4

T-O (am): 1.23 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score
GENETEC | GENETEC TECHNOLOGY BERHAD

GENETEC Support & Resistance

ATR Trailing Stop: 1.11

Support
Last Price
Resistance
Price 0.82 0.84 0.98 1.12 1.13 1.18 1.27 1.3 1.34 1.93 1.95
Volume (M) 183.1 84.5 55.0 48.0 33.4 97.3 20.0 46.2 22.1 85.1

Gann Support: 1.16/1.11 | Resistance: 1.21/1.27

*Highlighted column shows significant volume at the support or resistance area.

GENETEC Technical Trend

GENETEC Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

GENETEC Pivot Point

S2
S1
P
R1
R2
Daily 1.13 1.16 1.2 1.23 1.27
Weekly 1.05 1.12 1.19 1.26 1.33

GENETEC Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

GENETEC Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
26 Nov 24 Q1 Sep 24 1 30 Jun 25 40.20 4.43 4.77 11.9% 0.00 0.61 21.9% 44.5% 53.1% 74.2%
29 Aug 24 30 Jun 24 Other 30 Jun 24 51.49 7.63 10.16 19.7% 2.00 1.32 26.9% 32.0% 39.7% 41.5%
28 May 24 31 Mar 24 Other 30 Jun 24 70.47 19.06 16.84 23.9% 0.00 2.21 8.4% 10.1% 27.7% 1.5%
27 Feb 24 31 Dec 23 Other 30 Jun 24 76.91 25.16 23.29 30.3% 0.00 3.07 6.2% 9.7% 26.2% 82.5%
28 Nov 23 30 Sep 23 Other 30 Jun 24 72.44 18.75 18.45 25.5% 0.00 2.45 4.3% 2.5% 6.2% 26.4%
29 Aug 23 Q1 Jun 23 1 31 Mar 24 75.70 19.79 17.38 23.0% 0.00 2.32 3.4% 3.4% 1.7% 6.0%
31 May 23 Q4 Mar 23 4 31 Mar 23 78.39 19.03 17.09 21.8% 0.00 2.48 7.9% 33.5% 34.0% 25.4%
27 Feb 23 Q3 Dec 22 3 31 Mar 23 85.14 13.88 12.76 15.0% 0.00 1.87 20.5% 30.5% 49.1% 30.2%
28 Nov 22 Q2 Sep 22 2 31 Mar 23 70.66 27.94 25.05 35.5% 0.00 3.67 3.5% 19.1% 35.5% 53.6%
29 Aug 22 Q1 Jun 22 1 31 Mar 23 73.21 19.44 18.49 25.3% 0.00 2.71 24.7% 81.8% 35.7% 126.0%
26 May 22 Q4 Mar 22 4 31 Mar 22 58.70 14.84 13.63 23.2% 0.00 2.00 10.1% 349.3% 25.5% 339.7%
26 Jan 22 Q3 Dec 21 3 31 Mar 22 65.26 21.01 18.28 28.0% 0.00 35.83 10.0% 98.3% 12.1% 1956.5%
25 Oct 21 Q2 Sep 21 2 31 Mar 22 59.31 17.59 16.31 27.5% 0.00 32.25 47.3% 53.4% 99.3% 518.3%
29 Jul 21 Q1 Jun 21 1 31 Mar 22 40.28 8.86 8.18 20.3% 0.00 16.28 208.3% 224.1% 243.9% 491.7%
25 May 21 Q4 Mar 21 4 31 Mar 21 13.07 -6.56 -5.68 -43.5% 0.00 -13.03 60.3% 57.0% 739.5% 27.3%
09 Feb 21 Q3 Dec 20 3 31 Mar 21 32.91 0.84 0.89 2.7% 0.00 2.06 14.9% 17.9% 66.3% 89.5%
25 Nov 20 Q2 Sep 20 2 31 Mar 21 38.67 2.69 2.64 6.8% 0.00 6.18 211.2% 167.0% 226.3% 1489.2%
27 Aug 20 Q1 Jun 20 1 31 Mar 21 12.43 -1.79 -2.09 -16.8% 0.00 -4.93 49.4% 28.7% 73.3% 118.5%
24 Jun 20 Q4 Mar 20 4 31 Mar 20 8.32 -8.74 -7.82 -94.0% 0.00 -18.50 79.2% 42.0% 192.6% 109.6%
26 Feb 20 Q3 Dec 19 3 31 Mar 20 40.11 8.12 8.45 21.1% 0.00 19.97 176.9% 16.2% 4987.9% 69.2%
25 Nov 19 Q2 Sep 19 2 31 Mar 20 14.48 -0.19 0.17 1.1% 0.00 0.39 16.9% 25.7% 117.4% 75.5%
28 Aug 19 Q1 Jun 19 1 31 Mar 20 17.42 -0.51 -0.96 -5.5% 0.00 -2.26 21.4% 39.5% 74.4% 126.0%
28 May 19 Q4 Mar 19 4 31 Mar 19 14.36 -5.56 -3.73 -26.0% 0.00 -9.19 58.4% 50.6% 174.8% 2247.2%
26 Feb 19 Q3 Dec 18 3 31 Mar 19 34.52 5.06 4.99 14.5% 2.50 12.42 77.1% 25.7% 636.1% 83.3%
28 Nov 18 Q2 Sep 18 2 31 Mar 19 19.50 0.84 0.68 3.5% 0.00 1.71 32.3% 0.1% 81.6% 170.0%
21 Aug 18 Q1 Jun 18 1 31 Mar 19 28.79 3.89 3.68 12.8% 2.50 9.32 0.9% 14.9% 2412.6% 89.0%
22 May 18 Q4 Mar 18 4 31 Mar 18 29.05 0.19 -0.16 -0.6% 0.00 -0.44 5.8% 58.8% 105.8% 91.9%
28 Feb 18 Q3 Dec 17 3 31 Mar 18 27.47 3.66 2.72 9.9% 0.00 7.67 41.1% 91.3% 381.3% 221.9%
21 Nov 17 Q2 Sep 17 2 31 Mar 18 19.47 -0.53 -0.97 -5.0% 0.00 -2.72 22.3% 21.3% 149.8% 64.3%
29 Aug 17 Q1 Jun 17 1 31 Mar 18 25.05 2.58 1.95 7.8% 0.00 5.53 37.0% 14.2% 199.2% 110.3%
24 May 17 Q4 Mar 17 4 31 Mar 17 18.29 -2.01 -1.96 -10.7% 0.00 -5.57 27.4% 10.3% 12.3% 60.8%
24 Feb 17 Q3 Dec 16 3 31 Mar 17 14.36 -1.87 -2.23 -15.6% 0.00 -6.35 10.6% 27.5% 279.3% 9.7%
22 Nov 16 Q2 Sep 16 2 31 Mar 17 16.05 -0.52 -0.59 -3.7% 0.00 -1.67 26.8% 58.6% 163.7% 118.7%
24 Aug 16 Q1 Jun 16 1 31 Mar 17 21.93 0.81 0.93 4.2% 0.00 2.63 32.2% 59.3% 175.9% 79.5%
24 May 16 Q4 Mar 16 4 31 Mar 16 16.59 -0.09 -1.22 -7.3% 0.00 -3.47 16.2% 65.8% 40.2% 164.3%
24 Feb 16 Q3 Dec 15 3 31 Mar 16 19.80 -1.33 -2.04 -10.3% 0.00 -0.58 48.9% 49.6% 164.5% 230.5%
18 Nov 15 Q2 Sep 15 2 31 Mar 16 38.78 3.71 3.16 8.1% 0.00 0.90 28.0% 41.2% 29.9% 447.0%
19 Aug 15 Q1 Jun 15 1 31 Mar 16 53.84 5.97 4.50 8.4% 0.00 1.28 11.1% 75.6% 137.6% 967.1%
29 May 15 Q4 Mar 15 4 31 Mar 15 48.46 0.69 1.90 3.9% 0.00 0.54 23.3% 158.1% 21.4% 38.8%
13 Feb 15 31/12/14 3 31/03/15 39.30 1.70 1.56 4.0% 0.00 0.44 43.1% 63.6% 170.5% 619.4%

GENETEC Historical Dividends

GENETEC Financial Ratios

EPS 7.01 sen
Trailing PE (Sector Median: 27.7) 16.8
PEG 16.8
Altman Z 1.7
Beaver 0.451
Current Ratio 4.7
Debt-Equity (DE) Ratio 0.22
FCF Yield 2.5 %
Revenue QoQ -21.92 %
Revenue YoY -44.5%
Profit QoQ -53.06 %
Profit YoY -74.16 %
Profit Margin (Sector Median: 7.3) 23.03 %
ROE (ROIC: 15.85) 15.98 %
Dividend Per Share (DPS) 2.0 sen
Dividend Yield (DY) 1.69 %

GENETEC Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 27.7)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 7.3)
ROE (ROIC: 14.91)
Altman Z

GENETEC Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.61
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 4.77
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

GENETEC Directors Share Purchases (Beta)


MR TEH KIM SENG reduced 300000.0 units announced on 27 Apr 2023 at ~RM2.78

MR TAN MOON TEIK reduced 1200000.0 units announced on 30 Jan 2023 at ~RM2.72

MADAM ONG PHOE BE reduced 30000.0 units announced on 27 Dec 2022 at ~RM2.68

MADAM ONG PHOE BE reduced 40000.0 units announced on 19 Dec 2022 at ~RM2.71

MR CHIN KEM WENG added 20000.0 units announced on 15 Nov 2021 at ~RM41.9

MADAM ONG PHOE BE reduced 500.0 units announced on 08 Sep 2021 at ~RM29.08

MADAM ONG PHOE BE reduced 5000.0 units announced on 01 Sep 2021 at ~RM29.4

MADAM ONG PHOE BE reduced 5000.0 units announced on 16 Aug 2021 at ~RM25.68

MR TEH KIM SENG reduced 100000.0 units announced on 24 Jun 2021 at ~RM5.67

MR TAN MOON TEIK added 40000.0 units announced on 25 Feb 2021 at ~RM5.51

MR TAN MOON TEIK added 38000.0 units announced on 24 Feb 2021 at ~RM5.66

MR TAN MOON TEIK added 183000.0 units announced on 22 Feb 2021 at ~RM5.55

MADAM ONG PHOE BE reduced 30000.0 units announced on 18 Feb 2021 at ~RM5.58

MR TAN MOON TEIK added 140000.0 units announced on 16 Feb 2021 at ~RM3.89

GENETEC Summary


Market Cap: 926 M.

Market Cap Class: Middlers

Number of Shares: 784 M.

Adjusted Float: 88.7%.

Stock highly correlated with

CEB (93%)

D&O (92%)

JIANKUN (92%)

CNASIA (91%)

Genetec Technology Berhad, an investment holding company, operates as a contract manufacturer of automated industrial equipment and production tools in Malaysia. It is engaged in designing and building of customized factory automation equipment and integrated vision inspection systems, and conceptual design and development of prototype and mass replication of equipment. The company's products include laser systems, pre-die inspection and post-die inspection vision system, auto unload stations, head gimbal assembly gramload machine, auto cut and fold machine, auto single alarm assembly game load machine, auto shunt machine, and oil fill machine. It also provides design, manufacture, and value-added services to the customers in the electronics, hard-disk, and semiconductor industries. Genetec Technology was founded in 1998 and is based in Bandar Baru Bangi, Malaysia.

Sectors: Technology, Trading & Services, Technology Equipment, Semiconductors, Automation, Electric Vehicles, Precision Machining

Code: 0104

Website: https://genetec.net

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

GENETEC Top Shareholdings

Updated on 24-Jul-2023

Shareholder % Value (M)
Chin Kem Weng 7.64% 70.76
KVC Corporation Sdn Bhd 6.18% 57.24
Chen Khai Voon 6.04% 55.94
Tan Moon Teik 5.16% 47.79
Chin Kim Weng 4.63% 42.88
Hong Leong Value Fund 3.86% 35.75
Employees Provident Fund Board 2.45% 22.69
Principal Dali Equity Growth Fund 2.37% 21.95
KGI Securities (Singapore) Pte. Ltd. 2.33% 21.58
CIMB Bank Berhad 1.47% 13.61
Hong Leong Balanced Fund 1.28% 11.85
Thana Ratnaubonchai 1.14% 10.56
Tan Moon Chong 1.08% 10.0
Phillip Securities Pte. Ltd. 1.05% 9.72
Principal Dali Asia Pacific Equity Growth Fund 0.98% 9.08
Tan Kon Hoan 0.93% 8.61
Leong Kah Kong 0.9% 8.34
Kenanga Shariah Growth Opportunities Fund 0.78% 7.22
Kenanga Growth Fund 0.78% 7.22
Ubs (Lux) Key Selection Sicav-Asian Equities (Usd) 0.76% 7.04
Principal Islamic Small Cap Opportunities Fund 0.76% 7.04
Manulife Investment Shariah Progress Fund 0.75% 6.95
Prulink Strategic Fund 0.74% 6.85
Sow Ewe Lee 0.69% 6.39
Urusharta Jamaah Sdn. Bhd. 0.69% 6.39
Principal Dali Equity Fund 0.67% 6.21
Principal Dali Opportunities Fund 0.67% 6.21
Chin Kit Sen 0.61% 5.65
Allen Lik-Hook Ting 0.26% 2.4
Madam Ong Phoe Be 0.11% 1.03
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.